By using SoloCheck.co.uk you consent to the use of cookies in accordance with our cookie policy. See our Cookie Policy.

ORAAPHARMA LTD


3 views

Summary


ORAAPHARMA LTD was set up on Wednesday, March 18, 2020. Their current partial address is UNIT H ABBEYGATE BUSINESS CENTRE and the company status is Active.

Credit Score


Latest Accounts Filed:

31/12/2023

Next Set of Accounts Due:

30/09/2025

Company Vitals


Company Name:

ORAAPHARMA LTD

Time in Business:

5 years

Company Number:

12522745

Current Status:

Active

Company Category:

Private Limited Company

Country of Origin:

United Kingdom

Principal Activity:

[46460] - Wholesale of pharmaceutical goods

Registered Address:

UNIT H ABBEYGATE BUSINESS CENTRE
HITCHIN ROAD
LUTON
BEDFORDSHIRE
ENGLAND
LU2 0ER

Previous Names:

DAWABAPHARMA LTD

Filing History


Submission Date Type
Confirmation statement with updates 2025-03-03 CS01
Notification of a person with significant control 2025-03-03 PSC01
Appoint person director company with name date 2025-03-03 AP01
Termination director company with name termination date 2025-03-03 TM01
Cessation of a person with significant control 2025-03-03 PSC07
Accounts with accounts type total exemption full 2025-01-21 AA
Confirmation statement with no updates 2024-06-18 CS01
Confirmation statement with no updates 2023-06-19 CS01
Accounts with accounts type dormant 2023-03-14 AA
Accounts with accounts type dormant 2023-03-14 AA
Change account reference date company previous shortened 2023-02-28 AA01
Change registered office address company with date old address new address 2022-11-10 AD01
Confirmation statement with no updates 2022-07-03 CS01
Accounts with accounts type dormant 2021-11-08 AA
Change to a person with significant control 2021-11-08 PSC04
Confirmation statement with updates 2021-06-04 CS01
Change registered office address company with date old address new address 2021-06-04 AD01
Confirmation statement with updates 2021-04-29 CS01
Certificate change of name company 2020-10-28 CERTNM
Cessation of a person with significant control 2020-10-27 PSC07